Top Markets
Coin of the day
Taihe Group, Inc. Taihe Group, Inc.

Taihe Group, Inc.

TIHE
Rank in Stocks #23567
Currently, Taihe Group, Inc. is not engaged in substantial operational... Currently, Taihe Group, Inc. is not engaged in substantial operational activities. Historically, the company functioned as a commercial laboratory, providing specialized predictive tests for chemosensitivity and immunotherapy on biopsy samples, alongside a variety of other laboratory services and products within the field of oncology. Established in 1994, the Scottsdale, Arizona-based entity was formerly known as NuOncology Labs, Inc. until it adopted the name Taihe Group, Inc. in April 2022.
Share Price
$1.00
Last synced: 2025-04-10
Market Cap
$71.85M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Taihe Group, Inc. (TIHE)

Category

P/S ratio for Taihe Group, Inc. (TIHE)
P/S ratio as of 2026 TTM: 0
According to Taihe Group, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Taihe Group, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
5.80 -
US